Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Tamkus, Deimante

Cook County Health And Hospital System
United States

Stroger Hospital of Cook County (SHCC) MU-NCORP 3UG1CA190000-12S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tamkus, Deimante

Cook County Health And Hospital System
United States

Stroger Hospital of Cook County (SHCC) MU-NCORP 3UG1CA190000-12S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tanasova, Marina

Michigan Technological University
United States

Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications 2R15CA242401-02A1 Wendy Wang, Ph.D., M.Sc.
Taouli, Bachir

Icahn School Of Medicine At Mount Sinai
United States

Abbreviated MRI for HCC screening in cirrhotic patients 5R01CA249765-05 Guillermo Marquez, Ph.D.
Taratula, Oleh

Oregon State University
United States

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia 5R37CA234006-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Taratula, Oleh

Oregon State University
United States

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia 5R37CA234006-07 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tayob, Nabihah

Dana-Farber Cancer Inst
United States

Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma 5R01CA230503-07 Nicholas Hodges, Ph.D.
Tearney, Guillermo J

Massachusetts General Hospital
United States

Colorectal Cancer Screening with Optical Coherence Tomography 5R01CA280972-02 Matthew Young, Ph.D.
Temprosa, Marinella

George Washington University
United States

22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tennis, Meredith A

University Of Colorado Denver
United States

Modeling lung squamous cell carcinoma premalignancy and prevention 1R01CA298925-01
Tennis, Meredith A

University Of Colorado Denver
United States

Persistence and regression in lung premalignant lesions 1R01CA289576-01A1 Malgorzata Wojtowicz, M.D.
Terry, Kathryn L.

Brigham And Women'S Hospital
United States

Changing Contraceptive Patterns and Ovarian Cancer Risk 5R01CA258679-05 Goli Samimi, Ph.D., M.P.H.
Tewari, Ashutosh K

Icahn School Of Medicine At Mount Sinai
United States

Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men 1R01CA290438-01A1 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Thakur, Mathew Laxman

Thomas Jefferson University
United States

Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer 5R01CA249921-05
Thangaraju, Muthusamy

Augusta University
United States

Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis 5R01CA275840-03

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials